James D Campbell

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea
    James D Campbell
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Entebbe, Uganda
    Clin Infect Dis 54:1204-11. 2012
  2. ncbi Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults
    James D Campbell
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA
    Hum Vaccin 7:81-8. 2011
  3. ncbi Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda
    Fatu Forna
    Global AIDS Program, National Center for HIV, Hepatitis, STD, and TB Prevention NCHHSTP, CDC, Atlanta, Georgia, USA
    J Int Assoc Physicians AIDS Care (Chic) 8:128-38. 2009
  4. ncbi Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector
    Jakub K Simon
    Division of Geomedicine, Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, United States
    Vaccine 29:9544-50. 2011

Collaborators

Detail Information

Publications4

  1. ncbi HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea
    James D Campbell
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Entebbe, Uganda
    Clin Infect Dis 54:1204-11. 2012
    ..Many countries recommend that individuals taking antiretroviral therapy (ART) discontinue cotrimoxazole when CD4 counts are >200 cells/μL. However, this practice has not been evaluated in sub-Saharan Africa...
  2. ncbi Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults
    James D Campbell
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA
    Hum Vaccin 7:81-8. 2011
    ..In conclusion, the newly-licensed vaccine was well tolerated and immunologically non-inferior to the established vaccine for all three vaccine strains in the whole population and the elderly...
  3. ncbi Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda
    Fatu Forna
    Global AIDS Program, National Center for HIV, Hepatitis, STD, and TB Prevention NCHHSTP, CDC, Atlanta, Georgia, USA
    J Int Assoc Physicians AIDS Care (Chic) 8:128-38. 2009
    ..The authors evaluated hematologic changes associated with zidovudine (ZDV) following single-drug substitution from stavudine (D4T) in HIV-infected persons in Uganda...
  4. ncbi Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector
    Jakub K Simon
    Division of Geomedicine, Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, United States
    Vaccine 29:9544-50. 2011
    ..In the first study in humans, the newly-US-licensed LectraJet(®) model M3 RA DSJI was compared to N-S...